Application of BAPTA derivative in the preparing process of clinical medicine
Patent Information
- Authority / Receiving Office
- CN ยท China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- HENGXING PHARMA INST HEFEI
- Publication Date
- 2005-04-13
- Estimated Expiration
- Not applicable ยท inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
1. Technical field
[0001] The present invention relates to a novel use of a derivative of a known compound, specifically the application of BAPTA and its derivatives in the preparation of clinical medicines. It is used for the rescue and treatment of patients with acute massive cell death. 2. Background technology
[0002] Ischemia and hypoxia are the main causes of acute mass cell death in the human body, such as ischemic stroke and myocardial infarction leading to the death of brain cells and cardiomyocytes. In recent years, the research on the mechanism of cell death related to ischemia and hypoxia has made great progress, which points out the direction and provides a theoretical basis for the research and development of powerful drugs to protect cells from death.
[0003] Mr. Zhang Juntian, a famous pharmacologist, discussed intracellular calcium overload in the book "Modern Pharmacological Experimental Methods" and pointed out that intracellular calcium overload caused...